|
Oct 14
|
Roche Wins FDA Nod for Breast Cancer Drug in First-Line Setting
|
|
Oct 14
|
Genentech’s Evrysdi helped babies with SMA reach rare milestones in Phase II trial
|
|
Oct 14
|
Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
|
|
Oct 14
|
Majority of Children With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Are Able to Sit, Stand and Walk Independently, Two-Year Data Demonstrate
|
|
Oct 11
|
Roche wins first-line approval for PI3K inhibitor combo in breast cancer
|
|
Oct 11
|
Roche’s VENTANA CLDN18 assay gains CE mark
|
|
Oct 11
|
FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff
|
|
Oct 11
|
FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
|
|
Oct 10
|
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
|
|
Oct 10
|
Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
|
|
Oct 10
|
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
|
|
Oct 10
|
Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
|
|
Oct 9
|
OmniAb Inc (OABI) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ...
|
|
Oct 9
|
Lineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ...
|
|
Oct 9
|
Scholar Rock Holding Corp (SRRK) Q2 2024 Earnings Call Highlights: Advancing Key Milestones in ...
|
|
Jul 30
|
European Commission approves Roche’s Vabysmo for treatment of retinal vein occlusion (RVO)
|
|
Jul 29
|
Affimed (AFMD) to Report Q2 Earnings: What's in the Cards?
|
|
Jul 29
|
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
|
|
Jul 29
|
Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
|
|
Jul 29
|
Roche acquires Point of Care technology from LumiraDx
|